BRIEF published on 10/31/2024 at 06:35, 21 days 7 hours ago R&S Group Outlines Capital Expenditures and Updates FCF Guidance Free Cash Flow Share Conversion Capital Expenditures R&S Group Growth Kyte Powertech Integration
PRESS RELEASE published on 10/31/2024 at 06:30, 21 days 7 hours ago R&S Group publishes capital expenditures plans and updates FCF guidance accordingly R&S Group Holding AG updates free cash flow guidance and capital expenditures plans at its first Capital Markets Day, including strategic initiatives and growth drivers R&S Group Holding AG Free Cash Flow Strategic Initiatives Capital Markets Day Capital Expenditures
BRIEF published on 10/08/2024 at 07:05, 1 month 13 days ago R&S Group Announces Early Redemption of Warrants Warrants Shares SIX Swiss Exchange R&S Group Early Redemption
PRESS RELEASE published on 10/08/2024 at 07:00, 1 month 13 days ago R&S Group informs about intended early redemption of warrants R&S Group Holding AG informs about the intended early redemption of warrants triggering a redemption process for listed securities on SIX Swiss Exchange Warrants SIX Swiss Exchange R&S Group Early Redemption Redemption Process
BRIEF published on 10/01/2024 at 17:50, 1 month 19 days ago R&S Group Warrants Converted by 79% Shares Market Capitalization R&S Group Warrants Conversion Equity And Liquidity
PRESS RELEASE published on 10/01/2024 at 17:45, 1 month 19 days ago R&S Group warrants converted by 79% R&S Group Holding AG announces 79% conversion of warrants, strengthening equity and liquidity by CHF 60.8 million. Total of 5,294,098 warrants converted to registered shares Liquidity SIX Swiss Exchange R&S Group Equity Warrants Conversion
BRIEF published on 09/11/2024 at 06:35, 2 months 10 days ago R&S Group Releases Semi-Annual Report 2024 Financial Results Order Intake R&S Group Semi-Annual Report Equity Conversion
PRESS RELEASE published on 09/11/2024 at 06:30, 2 months 10 days ago R&S Group published semi-annual report 2024 R&S Group Holding AG published its semi-annual report 2024, revealing significant growth in key figures. Join the conference call on 11 September 2024 for detailed insights Financial Results Conference Call R&S Group Holding AG Key Figures Semi-annual Report 2024
BRIEF published on 08/28/2024 at 06:35, 2 months 24 days ago R&S Group Expands Shareholder Base, Boosts Free Float SIX Swiss Exchange R&S Group Free Float Shareholder Base Veraison SICAV
PRESS RELEASE published on 08/28/2024 at 06:30, 2 months 24 days ago R&S Group further increases free float by broadening shareholder base R&S Group increases free float by selling shares to Swiss and international investors, enhancing liquidity. Veraison exits its position Liquidity Shareholders Investors R&S Group Free Float
Published on 11/21/2024 at 13:30, 29 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
